Yep, there it is again in your last paragraph attributing...

Yep, there it is again in your last paragraph attributing success to management (read MH as we know of no other exec) even a year in advance of guesswork outcomes with your certainty of “should” not “could” ....more curious than the usual congratulatory spin on each failure or mediocre ann.

This misplaced support for more of the same management failure to implement is a disservice to all shareholders. It also sends the wrong message of unconditional support to management. But of course that’s your call and Tsuba, Leverage, T7 ... nothing tangible has been achieved, the sp reflects that. You appear to have no concern of the consequential wealth destruction.

The loyalists encourage us to patiently wait for the next AGM to hopefully hear of any material achievement, or the next quarterly, next million dollar day, Midkine Conference, clinical collaboration, NM stock levels, Pacific Edge, a “name” joining the Board, institutional investors on the register or perhaps being told one day the Evolis sales through 1800 Aussie pharmacies have broken through the multi year average of $92 per MONTH.

When the CEO friendly hand picked Board opportunistically heralds any normal business achievement as a “milestone” it could again (going by the acquiescence here) expect to have majority support for another $185,000 CEO hand out dressed up as an incentive and/or golden handcuff.

The point remains that despite all the opportunities passing it by year on year this management has few tangible achievements and has overseen a record low sp of half its hitherto long term average.